259 related articles for article (PubMed ID: 31171967)
21. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
Koksal F; Ak K; Kucukbasmaci O; Samasti M
Chemotherapy; 2009; 55(4):293-7. PubMed ID: 19521075
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study.
Quan J; Li X; Chen Y; Jiang Y; Zhou Z; Zhang H; Sun L; Ruan Z; Feng Y; Akova M; Yu Y
Lancet Infect Dis; 2017 Apr; 17(4):400-410. PubMed ID: 28139430
[TBL] [Abstract][Full Text] [Related]
24. Trends in antimicrobial resistance in bloodstream infections at a large tertiary-care hospital in China: a 10-year retrospective study (2010-2019).
Liu C; Xu M; Li X; Dong H; Ming L
J Glob Antimicrob Resist; 2022 Jun; 29():413-419. PubMed ID: 34800707
[TBL] [Abstract][Full Text] [Related]
25. Evaluating state-specific antibiotic resistance measures derived from central line-associated bloodstream infections, national healthcare safety network, 2011.
Soe MM; Edwards JR; Sievert DM; Ricks PM; Magill SS; Fridkin SK
Infect Control Hosp Epidemiol; 2015 Jan; 36(1):54-64. PubMed ID: 25627762
[TBL] [Abstract][Full Text] [Related]
26. Trends in Expanded-Spectrum Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae among Dutch Clinical Isolates, from 2008 to 2012.
van der Steen M; Leenstra T; Kluytmans JA; van der Bij AK;
PLoS One; 2015; 10(9):e0138088. PubMed ID: 26381746
[TBL] [Abstract][Full Text] [Related]
27. Interspecies differences in clinical characteristics and risk factors for third-generation cephalosporin resistance between Escherichia coli and Klebsiella pneumoniae bloodstream infection in patients with liver cirrhosis.
Ham SY; Jung H; Song KH; Jeong H; Jung J; Moon SM; Park JS; Kim NH; Jang ES; Kim JW; Jeong SH; Kim ES; Kim HB
Eur J Clin Microbiol Infect Dis; 2022 Dec; 41(12):1459-1465. PubMed ID: 36227508
[TBL] [Abstract][Full Text] [Related]
28. [Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].
Wang X; Zhao C; Li H; Chen H; Jin L; Wang Z; Liao K; Zeng J; Xu X; Jin Y; Su D; Liu W; Hu Z; Cao B; Chu Y; Zhang R; Luo Y; Hu B; Wang H
Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1205-1217. PubMed ID: 30152206
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology and antimicrobial susceptibility of Gram-negative aerobic bacteria causing intra-abdominal infections during 2010-2011.
Hawser S; Hoban DJ; Badal RE; Bouchillon SK; Biedenbach D; Hackel M; Morrissey I
J Chemother; 2015 Feb; 27(2):67-73. PubMed ID: 24548089
[TBL] [Abstract][Full Text] [Related]
30. Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Fransén J; Huss FR; Nilsson LE; Rydell U; Sjöberg F; Hanberger H
Burns; 2016 Sep; 42(6):1295-303. PubMed ID: 27241732
[TBL] [Abstract][Full Text] [Related]
31. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and meticillin-resistant Staphylococcus aureus in a long-term care facility over one year.
Ludden C; Cormican M; Vellinga A; Johnson JR; Austin B; Morris D
BMC Infect Dis; 2015 Apr; 15():168. PubMed ID: 25887288
[TBL] [Abstract][Full Text] [Related]
32. Apramycin efficacy against carbapenem- and aminoglycoside-resistant Escherichia coli and Klebsiella pneumoniae in murine bloodstream infection models.
Frimodt-Møller N; Hansen JU; Plattner M; Huseby DL; Radmer Almind S; Haldimann K; Gysin M; Petersson A; Ercan O; Ganz L; Hughes D; Vingsbo Lundberg C; Hobbie SN
Int J Antimicrob Agents; 2024 Jul; 64(1):107181. PubMed ID: 38653351
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiological analysis of pathogens causing bloodstream infections in department of hematology in Guangdong Province].
Zhuo CY; Guo YY; Liu NJ; Liu BM; Xiao SN; Zhang Y; Guo XC; Li DN; Tan SY; He NH; Mai Y; Guan J; Zhuo C
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):996-1001. PubMed ID: 33445846
[No Abstract] [Full Text] [Related]
34. Epidemiology of bacteremia in young hospitalized infants in Vientiane, Laos, 2000-2011.
Anderson M; Luangxay K; Sisouk K; Vorlasan L; Soumphonphakdy B; Sengmouang V; Chansamouth V; Phommasone K; Van Dyke R; Chong E; Dance DA; Phetsouvanh R; Newton PN
J Trop Pediatr; 2014 Feb; 60(1):10-6. PubMed ID: 23902672
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
36. Long-term study of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
Polwichai P; Trakulsomboon S; Dejsirilert S; Thongmali O; Sawanpanyalert P; Aswapokee N; Buppanharun W
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S53-8. PubMed ID: 21294502
[TBL] [Abstract][Full Text] [Related]
37. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017.
Kohler P; Fulchini R; Albrich WC; Egli A; Balmelli C; Harbarth S; Héquet D; Kahlert CR; Kuster SP; Petignat C; Schlegel M; Kronenberg A
Antimicrob Resist Infect Control; 2018; 7():88. PubMed ID: 30038781
[TBL] [Abstract][Full Text] [Related]
38. Antimicrobial resistance of major clinical pathogens in South Korea, May 2016 to April 2017: first one-year report from Kor-GLASS.
Lee H; Yoon EJ; Kim D; Jeong SH; Won EJ; Shin JH; Kim SH; Shin JH; Shin KS; Kim YA; Uh Y; Yang JW; Kim IH; Park C; Lee KJ
Euro Surveill; 2018 Oct; 23(42):. PubMed ID: 30352640
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study.
Djuric O; Jovanovic S; Stosovic B; Tosic T; Jovanovic M; Markovic-Denic L
J Infect Dev Ctries; 2016 Dec; 10(12):1325-1331. PubMed ID: 28036312
[TBL] [Abstract][Full Text] [Related]
40. Infection in burn patients in a referral center in Colombia.
Ramirez-Blanco CE; Ramirez-Rivero CE; Diaz-Martinez LA; Sosa-Avila LM
Burns; 2017 May; 43(3):642-653. PubMed ID: 28185802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
